Weitz Investment Management Has Lifted By $3.88 Million Its Allison Transmission Hldgs I (ALSN) Holding; Coherus Biosciences (CHRS) Sellers Increased By 0.88% Their Shorts

January 14, 2018 - By Peter Erickson

Weitz Investment Management Inc increased Allison Transmission Hldgs I (ALSN) stake by 15.87% reported in 2017Q3 SEC filing. Weitz Investment Management Inc acquired 104,795 shares as Allison Transmission Hldgs I (ALSN)’s stock rose 0.35%. The Weitz Investment Management Inc holds 765,100 shares with $28.71 million value, up from 660,305 last quarter. Allison Transmission Hldgs I now has $6.29B valuation. The stock decreased 0.83% or $0.37 during the last trading session, reaching $44.39. About 1.90 million shares traded or 13.90% up from the average. Allison Transmission Holdings, Inc. (NYSE:ALSN) has risen 38.35% since January 14, 2017 and is uptrending. It has outperformed by 21.65% the S&P500.

Coherus Biosciences Incorporated (NASDAQ:CHRS) had an increase of 0.88% in short interest. CHRS’s SI was 5.96 million shares in January as released by FINRA. Its up 0.88% from 5.90 million shares previously. With 667,800 avg volume, 9 days are for Coherus Biosciences Incorporated (NASDAQ:CHRS)’s short sellers to cover CHRS’s short positions. The SI to Coherus Biosciences Incorporated’s float is 15.51%. The stock decreased 0.73% or $0.1 during the last trading session, reaching $13.6. About 894,791 shares traded or 45.30% up from the average. Coherus Biosciences, Inc. (NASDAQ:CHRS) has risen 17.62% since January 14, 2017 and is uptrending. It has outperformed by 0.92% the S&P500.

Since August 1, 2017, it had 0 insider purchases, and 11 selling transactions for $37.06 million activity. $288,872 worth of Allison Transmission Holdings, Inc. (NYSE:ALSN) shares were sold by Dick Michael. Graziosi David S. also sold $2.08 million worth of Allison Transmission Holdings, Inc. (NYSE:ALSN) shares. Kirk Randall R. had sold 7,283 shares worth $275,193 on Thursday, August 3. On Wednesday, January 3 STAR JAMES A sold $28.45M worth of Allison Transmission Holdings, Inc. (NYSE:ALSN) or 640,835 shares. Scroggins Eric C. also sold $190,533 worth of Allison Transmission Holdings, Inc. (NYSE:ALSN) on Wednesday, January 3.

Among 20 analysts covering Allison Transmission Holdings (NYSE:ALSN), 8 have Buy rating, 3 Sell and 9 Hold. Therefore 40% are positive. Allison Transmission Holdings had 66 analyst reports since July 30, 2015 according to SRatingsIntel. The rating was maintained by Piper Jaffray on Wednesday, August 23 with “Sell”. The firm has “Mkt Outperform” rating by Avondale given on Wednesday, December 2. The stock of Allison Transmission Holdings, Inc. (NYSE:ALSN) earned “Neutral” rating by Citigroup on Friday, July 29. RBC Capital Markets maintained the shares of ALSN in report on Thursday, January 11 with “Buy” rating. The firm earned “Sell” rating on Friday, November 17 by Piper Jaffray. The rating was downgraded by Robert W. Baird on Monday, January 4 to “Neutral”. JP Morgan maintained the shares of ALSN in report on Monday, October 30 with “Neutral” rating. The stock of Allison Transmission Holdings, Inc. (NYSE:ALSN) earned “Neutral” rating by Seaport Global on Thursday, April 6. Citigroup maintained the shares of ALSN in report on Thursday, November 2 with “Buy” rating. On Wednesday, November 1 the stock rating was maintained by Buckingham Research with “Neutral”.

Weitz Investment Management Inc decreased Aon Plc (NYSE:AON) stake by 45,724 shares to 321,930 valued at $47.03M in 2017Q3. It also reduced Laboratory Corp Amer Hldgs (NYSE:LH) stake by 2,715 shares and now owns 761,375 shares. Liberty Interactive Corp (NASDAQ:QVCA) was reduced too.

Investors sentiment decreased to 1.06 in 2017 Q3. Its down 0.33, from 1.39 in 2017Q2. It worsened, as 39 investors sold ALSN shares while 84 reduced holdings. 50 funds opened positions while 80 raised stakes. 151.84 million shares or 0.94% less from 153.29 million shares in 2017Q2 were reported. The United Kingdom-based Barclays Public Ltd Company has invested 0.01% in Allison Transmission Holdings, Inc. (NYSE:ALSN). Moreover, Vanguard Grp has 0.02% invested in Allison Transmission Holdings, Inc. (NYSE:ALSN). Prelude Mngmt Ltd Liability Corporation accumulated 22,000 shares or 0.07% of the stock. Teachers Retirement System Of The State Of Kentucky has invested 0.04% in Allison Transmission Holdings, Inc. (NYSE:ALSN). Balyasny Asset Management Lc has 0.02% invested in Allison Transmission Holdings, Inc. (NYSE:ALSN). Aperio Lc holds 0.01% in Allison Transmission Holdings, Inc. (NYSE:ALSN) or 28,840 shares. Sg Americas Secs Ltd invested 0% of its portfolio in Allison Transmission Holdings, Inc. (NYSE:ALSN). Numeric Invsts Lc holds 0.63% or 2.17M shares. Hawaii-based C M Bidwell And Associate has invested 0.04% in Allison Transmission Holdings, Inc. (NYSE:ALSN). Enterprise Finance invested 0% of its portfolio in Allison Transmission Holdings, Inc. (NYSE:ALSN). Deutsche Fincl Bank Ag invested in 0.03% or 1.19 million shares. State Street Corporation reported 1.77M shares. Wellington Mngmt Gru Limited Liability Partnership holds 0.04% in Allison Transmission Holdings, Inc. (NYSE:ALSN) or 4.80M shares. Voya Invest Mgmt Ltd Liability Corporation holds 50,934 shares or 0% of its portfolio. 111,000 are owned by Art Advisors Ltd Liability Company.

Among 10 analysts covering Coherus Biosciences (NASDAQ:CHRS), 9 have Buy rating, 0 Sell and 1 Hold. Therefore 90% are positive. Coherus Biosciences had 18 analyst reports since September 3, 2015 according to SRatingsIntel. As per Monday, June 12, the company rating was maintained by Maxim Group. The stock of Coherus Biosciences, Inc. (NASDAQ:CHRS) has “Overweight” rating given on Monday, November 23 by Barclays Capital. As per Wednesday, September 7, the company rating was initiated by Maxim Group. The rating was maintained by Robert W. Baird on Thursday, September 7 with “Buy”. Zacks upgraded Coherus Biosciences, Inc. (NASDAQ:CHRS) on Thursday, September 3 to “Hold” rating. The firm has “Buy” rating given on Wednesday, September 27 by Credit Suisse. The rating was maintained by Cowen & Co on Monday, June 12 with “Buy”. The rating was initiated by Citigroup with “Buy” on Wednesday, July 27. The firm has “Outperform” rating by Robert W. Baird given on Wednesday, October 19. The rating was initiated by Credit Suisse on Wednesday, January 20 with “Outperform”.

Investors sentiment decreased to 1.07 in Q3 2017. Its down 1.02, from 2.09 in 2017Q2. It turned negative, as 21 investors sold Coherus Biosciences, Inc. shares while 23 reduced holdings. 9 funds opened positions while 38 raised stakes. 46.59 million shares or 17.08% more from 39.79 million shares in 2017Q2 were reported. Carlson Capital Limited Partnership has 0.17% invested in Coherus Biosciences, Inc. (NASDAQ:CHRS) for 728,419 shares. Group One Trading Limited Partnership holds 38,414 shares. Alliancebernstein Limited Partnership holds 28,720 shares or 0% of its portfolio. 154,026 are held by Wells Fargo Mn. 538,000 were reported by State Of Wisconsin Investment Board. Tower Cap Limited (Trc) holds 0% of its portfolio in Coherus Biosciences, Inc. (NASDAQ:CHRS) for 2,892 shares. Fmr Limited Liability reported 0.01% stake. Parallax Volatility Advisers Ltd Partnership accumulated 1,021 shares. Goldman Sachs Inc holds 0% of its portfolio in Coherus Biosciences, Inc. (NASDAQ:CHRS) for 146,597 shares. Jpmorgan Chase And holds 0.01% or 1.75M shares in its portfolio. Temasek Holdings (Private) Ltd holds 0.51% or 6.56 million shares in its portfolio. Pacad Investment Ltd has 16,800 shares. Rock Springs Capital Lp reported 638,400 shares. Knott David M holds 0.2% of its portfolio in Coherus Biosciences, Inc. (NASDAQ:CHRS) for 34,320 shares. Rhenman & Partners Asset Mgmt owns 180,000 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: